This trial will explore if text messages can reduce heart disease risk in people living with HIV.
- Cardiovascular Disease
1 Primary · 10 Secondary · Reporting Duration: 6 months
Blood sugar control
Body mass index
Number of cardiovascular risk factors controlled
Proportion of current smokers
Proportion of participants with controlled blood pressure
Proportion of patients on guideline-based therapy
Self-perceived cardiovascular risk
Systolic blood pressure
2 Treatment Groups
1 of 2
1 of 2
260 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention Arm · No Placebo Group · N/A
BehavioralExperimental Group · 1 Intervention: Digital Educational Messaging · Intervention Types: Behavioral
Control ArmNoIntervention Group · 1 Intervention: Control Arm · Intervention Types:
Screening: ~3 weeks
Reporting: 6 months
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,616 Previous Clinical Trials
47,117,936 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,312 Previous Clinical Trials
11,758,066 Total Patients Enrolled
Megan McLaughlin, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment open for the trial at this time?
"Unfortunately, based on the information available at clinicaltrials.gov, this trial is not currently seeking participants; however, it was posted on January 1st 2023 and last updated November 29th 2022. Fortunately for those in search of a medical study to join, there are 1139 other trials recruiting patients presently." - Anonymous Online Contributor